beta-alanine has been researched along with Glucose Intolerance in 2 studies
Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Savolainen, O | 1 |
| Lind, MV | 1 |
| Bergström, G | 1 |
| Fagerberg, B | 1 |
| Sandberg, AS | 1 |
| Ross, A | 1 |
| Ryder, JW | 1 |
| Bassel-Duby, R | 1 |
| Olson, EN | 1 |
| Zierath, JR | 1 |
2 other studies available for beta-alanine and Glucose Intolerance
| Article | Year |
|---|---|
Biomarkers of food intake and nutrient status are associated with glucose tolerance status and development of type 2 diabetes in older Swedish women.
Topics: alpha-Tocopherol; beta-Alanine; Biomarkers; Case-Control Studies; Cholesterol; Diabetes Mellitus, Ty | 2017 |
Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways.
Topics: Animals; beta-Alanine; Calcineurin; Deoxyglucose; Dietary Fats; Enzyme Activation; Gene Expression; | 2003 |